生物技术通报 ›› 2023, Vol. 39 ›› Issue (8): 159-164.doi: 10.13560/j.cnki.biotech.bull.1985.2023-0173

• 技术与方法 • 上一篇    下一篇

应用CRISPR/Cas9技术建立ERK激酶相分离荧光探针定点整合的稳定细胞株

杨玉梅1,2(), 张坤晓1,2()   

  1. 1.江苏海洋大学药学院,连云港 222005
    2.江苏海洋大学江苏省海洋药物活性分子筛选重点实验室,连云港 222005
  • 收稿日期:2023-03-02 出版日期:2023-08-26 发布日期:2023-09-05
  • 通讯作者: 张坤晓,男,博士,讲师,研究方向: 发育生物学;E-mail: 2015000022@jou.edu.cn
  • 作者简介:杨玉梅,女,硕士研究生,研究方向: 分子生物学;E-mail: yangyumei03@163.com

Establishing a Stable Cell Line with Site-specific Integration of ERK Kinase Phase-separated Fluorescent Probe Using CRISPR/Cas9 Technology

YANG Yu-mei1,2(), ZHANG Kun-xiao1,2()   

  1. 1. School of Pharmacy, Jiangsu Ocean University, Lianyungang 222005
    2. Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Jiangsu Ocean University, Lianyungang 222005
  • Received:2023-03-02 Published:2023-08-26 Online:2023-09-05

摘要:

旨在构建人AAVS1位点定点敲入的诱导表达型ERK-SPARK激酶荧光探针的人食管鳞癌细胞株(KYSE-150)。根据AAVS1位点的DNA序列设计和已公开ERK-SPAEK荧光探针碱基序列构建了两端带有750 bp同源臂的诱导型ERK-SPARK表达盒的同源重组供体质粒。其次,利用在线设计工具设计了 3个靶向AAVS1位点的 sgRNA,并克隆至 pX330 骨架质粒中得到3个能定点切割AAVS1位点的CRISPR/Cas9 打靶载体,将同源重组供体质粒分别与表达CRISPR/Cas9打靶载体共转染KYSE-150细胞,经Dox诱导表达24 h后进行嘌呤霉素抗性筛选和流式细胞分选,得到抵抗嘌呤霉素且表达GFP的细胞亚群。再应用 PCR鉴定基因型,以及 Western blot 检测蛋白表达。对获得的细胞群提取基因组DNA并进行PCR基因型鉴定,结果显示获得片段的大小与诱导型ERK-SPARK表达盒的大小一致。蛋白表达检测结果显示,该细胞群表达了ERK-SPARK探针融合蛋白。荧光探针成像实验结果显示,在未经Dox诱导表达条件下,细胞株有极少量泄漏表达;经Dox诱导表达后,GFP荧光蛋白在细胞质内均匀分布,无明显聚集成点现象;在加入EGF激活ERK激酶后,原本在细胞质内均匀分布的GFP绿色荧光聚集成高亮度的绿色液珠。成功获得了可诱导表达检测ERK激酶活性的SPARK荧光探针的稳定细胞株,解决了瞬时表达ERK-SPARK探针效率不稳定影响实验结果准确性的问题,为后续建立基于SPARK技术的高通量蛋白激酶抑制剂的筛选平台奠定了前期研究基础。

关键词: CRISPR/Cas9, AAVS1 安全港, 同源重组, SPARK荧光探针, 稳定细胞株, KYSE-150细胞, 细胞外调节蛋白激酶, 表皮生长因子

Abstract:

This work is aimed to construct a KYSE-150 cell line containing an inducible expressed ERK-SPARK kinase fluorescent sensor into the AAVS1 locus. The homologous recombination donor plasmid of the inducible ERK-SPARK expression cassette with 750 bp homology arms at both ends was constructed according to the DNA sequence design of the AAVS1 locus and the published base sequences of the ERK-SPAEK fluorescent probe. Secondly, three sgRNAs targeting the AAVS1 locus were designed using an online design tool, and cloned into the pX330 backbone plasmid. Three CRISPR/Cas9 targeting vectors capable of site-specific cutting of the AAVS1 locus were obtained. The homologous recombination donor plasmids and the expressed CRISPR/Cas9 targeting vectors were co-transfected into KYSE-150 cells, after Dox-induced expression for 24 h, puromycin resistance screening and flow cytometry were performed, and cell subpopulations resistant to puromycin and expressing GFP were obtained. Then PCR was used to identify the genotype, and Western blot was used to detect protein expression. Genomic DNA was extracted from the obtained cell population and the genotype was identified by PCR. The results showed that the size of the obtained fragment was consistent with the size of the inducible ERK-SPARK expression cassette. The results of protein expression detection showed that the cell population expressed the ERK-SPARK probe fusion protein. The results of fluorescent probe imaging experiments demonstrated that the cell line had a very small amount of leakage expression under the condition of no Dox-induced expression. After Dox-induced expression, the GFP fluorescent protein was evenly distributed in the cytoplasm without obvious aggregation into spots. After adding EGF to activate ERK kinase, the green fluorescence of GFP that was uniformly distributed in the cytoplasm gathered into high-brightness green droplets. A stable cell line that expressed the SPARK fluorescent probe after induction for detecting ERK kinase activity were successfully obtained, which may solve the problem that the unstable efficiency of the transiently expressed ERK-SPARK probe affected the accuracy of the experimental results, and may lay the preliminary research foundation for subsequent establishment of screening platform of a SPARK-based high-throughput protein kinase inhibitors.

Key words: CRISPR/Cas9, AAVS1 safe harbor, homologous recombination, SPARK fluorescent sensor, stable cell lines, KYSE-150 cells, ERK, EGF